Recurrent Ovarian Cancer Treatment in Ahmedabad — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist treatment for recurrent ovarian cancer treatment at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad.
On this page
- What this stage means
- Recommended treatment pathway
- Adjuvant therapy
- Outlook and survival data
- Booking
- FAQs
Recurrent ovarian cancer treatment — What does this stage mean?
Recurrent ovarian cancer is classified by platinum-free interval. Platinum-sensitive recurrence (over 6 months from last platinum) responds best to repeat platinum-based regimens, sometimes combined with secondary cytoreductive surgery in carefully selected patients. Platinum-resistant recurrence (under 6 months) is managed with non-platinum agents (PLD, weekly paclitaxel, topotecan, gemcitabine). PIPAC may be considered for peritoneal-predominant recurrence.
For broader information see our cancer overview and treatment page.
Recommended treatment pathway
Recurrent ovarian cancer is classified by platinum-free interval. Platinum-sensitive recurrence (over 6 months from last platinum) responds best to repeat platinum-based regimens, sometimes combined with secondary cytoreductive surgery in carefully selected patients. Platinum-resistant recurrence (under 6 months) is managed with non-platinum agents (PLD, weekly paclitaxel, topotecan, gemcitabine). PIPAC may be considered for peritoneal-predominant recurrence.
Adjuvant therapy
Bevacizumab added to chemotherapy benefits both sensitive and resistant recurrence. Olaparib, niraparib or rucaparib maintenance for BRCA-mutated and HRD-positive responders. Trabectedin-PLD for selected platinum-resistant cases.
Outlook
Highly variable; depends on platinum-free interval, response to repeat treatment, BRCA/HRD status, and access to maintenance therapies. Median survival 1-3 years after first recurrence in most series.
External authoritative reference: NCCN Guidelines and ESGO Recommendations.
Booking
For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.
FAQs
Where is recurrent ovarian cancer treatment performed in Ahmedabad?
Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.
What is the typical hospital stay?
For minimally invasive surgery (robotic or laparoscopic), hospital stay is typically 3-4 days. For cytoreductive surgery or HIPEC, stay extends to 7-10 days. Chemoradiation is outpatient over 5-7 weeks.
What is the likely outcome?
Highly variable; depends on platinum-free interval, response to repeat treatment, BRCA/HRD status, and access to maintenance therapies. Median survival 1-3 years after first recurrence in most series. Outcomes are stage-dependent and individual; the figures above are averages from published series.
Is fertility preservation possible?
Fertility preservation is not standard for this stage. Egg or embryo cryopreservation may be considered before chemotherapy if applicable.
Can I get a second opinion before deciding?
Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.
Consultation and Next Steps
For an individualised consultation on recurrent ovarian cancer treatment, share your reports on WhatsApp at +91 76988 00333. Dr. Nishtha Tripathi Patel provides a detailed assessment within 24-48 hours and arranges in-person consultation at Sterling Hospitals, KD Hospital, or Welcare Speciality Hospital in Ahmedabad based on your location and treatment requirements.
Bring the following to your first consultation: imaging studies (ultrasound, CT or MRI on CD), histopathology and biopsy reports, tumour marker results (CA-125, HE4, CEA where relevant), a list of current medications, and any prior treatment summaries. For patients travelling from outside Ahmedabad, scheduling can be arranged to complete consultation and any pre-op work-up in the fewest possible visits.
If you are exploring second-opinion options, see our second-opinion service page. Independent review of diagnosis, staging, and proposed treatment plans is provided at no cost via WhatsApp report review. You do not need to switch hospitals to obtain a second opinion.
For broader information about recurrent ovarian cancer treatment and related conditions, also see our complete ovarian cancer guide, HIPEC India guide, cervical cancer guide and robotic surgery guide.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.